0 XP   0   0   0

Novan Inc










Financial Health of Novan




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


Novan Inc
Buy, Hold or Sell?

Should you buy, hold or sell Novan?

I guess you are interested in Novan Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Novan

Let's start. I'm going to help you getting a better view of Novan Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Novan Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Novan Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Novan Inc. The closing price on 2022-12-07 was $1.25 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Novan Inc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Novan Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Novan earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Novan to the Biotechnology industry mean.
  • A Net Profit Margin of -144.2% means that $-1.44 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Novan Inc:

  • The MRQ is -144.2%. The company is making a huge loss. -2
  • The TTM is -743.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-144.2%TTM-743.7%+599.6%
TTM-743.7%YOY-789.5%+45.8%
TTM-743.7%5Y-757.2%+13.5%
5Y-757.2%10Y-1,008.2%+251.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-144.2%-223.6%+79.4%
TTM-743.7%-281.7%-462.0%
YOY-789.5%-344.8%-444.7%
5Y-757.2%-450.1%-307.1%
10Y-1,008.2%-541.0%-467.2%
1.1.2. Return on Assets

Shows how efficient Novan is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Novan to the Biotechnology industry mean.
  • -7.8% Return on Assets means that Novan generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Novan Inc:

  • The MRQ is -7.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.8%TTM-10.1%+2.3%
TTM-10.1%YOY-14.7%+4.6%
TTM-10.1%5Y-15.4%+5.3%
5Y-15.4%10Y-19.0%+3.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.8%-9.9%+2.1%
TTM-10.1%-8.9%-1.2%
YOY-14.7%-9.3%-5.4%
5Y-15.4%-11.7%-3.7%
10Y-19.0%-12.7%-6.3%
1.1.3. Return on Equity

Shows how efficient Novan is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Novan to the Biotechnology industry mean.
  • -72.5% Return on Equity means Novan generated $-0.72 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Novan Inc:

  • The MRQ is -72.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -92.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-72.5%TTM-92.4%+19.9%
TTM-92.4%YOY-351.9%+259.4%
TTM-92.4%5Y-100.1%+7.7%
5Y-100.1%10Y-85.5%-14.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-72.5%-12.0%-60.5%
TTM-92.4%-11.5%-80.9%
YOY-351.9%-10.8%-341.1%
5Y-100.1%-14.2%-85.9%
10Y-85.5%-15.2%-70.3%

1.2. Operating Efficiency of Novan Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Novan is operating .

  • Measures how much profit Novan makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Novan to the Biotechnology industry mean.
  • An Operating Margin of -134.3% means the company generated $-1.34  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Novan Inc:

  • The MRQ is -134.3%. The company is operating very inefficient. -2
  • The TTM is -739.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-134.3%TTM-739.4%+605.1%
TTM-739.4%YOY-789.5%+50.1%
TTM-739.4%5Y-750.0%+10.6%
5Y-750.0%10Y-1,003.0%+253.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-134.3%-207.3%+73.0%
TTM-739.4%-271.0%-468.4%
YOY-789.5%-325.9%-463.6%
5Y-750.0%-454.0%-296.0%
10Y-1,003.0%-537.1%-465.9%
1.2.2. Operating Ratio

Measures how efficient Novan is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.42 means that the operating costs are $2.42 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Novan Inc:

  • The MRQ is 2.419. The company is inefficient in keeping operating costs low. -1
  • The TTM is 8.357. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.419TTM8.357-5.938
TTM8.357YOY8.900-0.543
TTM8.3575Y11.193-2.835
5Y11.19310Y16.899-5.707
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4192.871-0.452
TTM8.3573.504+4.853
YOY8.9003.604+5.296
5Y11.1935.132+6.061
10Y16.8996.371+10.528

1.3. Liquidity of Novan Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Novan is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.40 means the company has $1.40 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Novan Inc:

  • The MRQ is 1.402. The company is just able to pay all its short-term debts.
  • The TTM is 3.091. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ1.402TTM3.091-1.689
TTM3.091YOY5.335-2.245
TTM3.0915Y2.785+0.306
5Y2.78510Y3.212-0.428
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4025.117-3.715
TTM3.0915.755-2.664
YOY5.3355.854-0.519
5Y2.7856.511-3.726
10Y3.2126.222-3.010
1.3.2. Quick Ratio

Measures if Novan is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Novan to the Biotechnology industry mean.
  • A Quick Ratio of 1.25 means the company can pay off $1.25 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Novan Inc:

  • The MRQ is 1.254. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 2.930. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.254TTM2.930-1.675
TTM2.930YOY5.016-2.087
TTM2.9305Y2.584+0.346
5Y2.58410Y3.020-0.436
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2544.284-3.030
TTM2.9304.664-1.734
YOY5.0164.787+0.229
5Y2.5845.218-2.634
10Y3.0205.182-2.162

1.4. Solvency of Novan Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Novan assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Novan to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.89 means that Novan assets are financed with 89.3% credit (debt) and the remaining percentage (100% - 89.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Novan Inc:

  • The MRQ is 0.893. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.805. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.893TTM0.805+0.088
TTM0.805YOY0.838-0.033
TTM0.8055Y1.023-0.218
5Y1.02310Y0.914+0.110
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8930.278+0.615
TTM0.8050.277+0.528
YOY0.8380.306+0.532
5Y1.0230.367+0.656
10Y0.9140.403+0.511
1.4.2. Debt to Equity Ratio

Measures if Novan is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Novan to the Biotechnology industry mean.
  • A Debt to Equity ratio of 833.9% means that company has $8.34 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Novan Inc:

  • The MRQ is 8.339. The company is unable to pay all its debts with equity. -1
  • The TTM is 7.744. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ8.339TTM7.744+0.595
TTM7.744YOY18.930-11.186
TTM7.7445Y6.316+1.427
5Y6.31610Y4.738+1.579
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.3390.315+8.024
TTM7.7440.317+7.427
YOY18.9300.319+18.611
5Y6.3160.403+5.913
10Y4.7380.462+4.276

2. Market Valuation of Novan Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Novan generates.

  • Above 15 is considered overpriced but always compare Novan to the Biotechnology industry mean.
  • A PE ratio of -5.59 means the investor is paying $-5.59 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Novan Inc:

  • The EOD is -2.996. Company is losing money. -2
  • The MRQ is -5.585. Company is losing money. -2
  • The TTM is -12.337. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-2.996MRQ-5.585+2.589
MRQ-5.585TTM-12.337+6.752
TTM-12.337YOY-10.770-1.567
TTM-12.3375Y-6.513-5.824
5Y-6.51310Y-6.602+0.088
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.996-8.986+5.990
MRQ-5.585-9.792+4.207
TTM-12.337-16.243+3.906
YOY-10.770-20.876+10.106
5Y-6.513-16.665+10.152
10Y-6.602-14.732+8.130
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Novan.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Novan Inc:

  • The MRQ is -11.014. Very Bad. -2
  • The TTM is 107.948. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ-11.014TTM107.948-118.962
TTM107.948YOY-9.105+117.052
TTM107.9485Y14.059+93.889
5Y14.05910Y-31.527+45.586
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.014-0.032-10.982
TTM107.9480.004+107.944
YOY-9.1050.016-9.121
5Y14.0590.006+14.053
10Y-31.5270.003-31.530

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Novan is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.05 means the investor is paying $4.05 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Novan Inc:

  • The EOD is 2.172. Good. +1
  • The MRQ is 4.048. Neutral. Compare to industry.
  • The TTM is 7.441. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD2.172MRQ4.048-1.876
MRQ4.048TTM7.441-3.393
TTM7.441YOY13.217-5.776
TTM7.4415Y-11.619+19.060
5Y-11.61910Y-6.790-4.829
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.1721.835+0.337
MRQ4.0482.006+2.042
TTM7.4412.774+4.667
YOY13.2173.453+9.764
5Y-11.6192.713-14.332
10Y-6.7902.402-9.192
2. Total Gains per Share

2.4. Latest News of Novan Inc

Does Novan Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Novan Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-12-02
14:00
EPI Health, a Novan Company, Executes a $15.0 Million Financing AgreementRead
2022-12-01
15:00
Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech ConferenceRead
2022-11-14
13:00
Novan Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateRead

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Novan Inc.

3.1. Institutions holding Novan Inc

Institutions are holding 16.21% of the shares of Novan Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30Armistice Capital, LLC6.14190.0531130710313071030
2022-06-30Vanguard Group Inc3.71080.000178971900
2022-06-30Renaissance Technologies Corp1.46640.0009312074-70591-18.4472
2022-06-30Geode Capital Management, LLC0.68060.000114483800
2022-06-30Wunderlich Securities Inc0.37190.0002791501950032.6907
2022-06-30GSA Capital Partners LLP0.29750.022263306-63815-50.2002
2022-06-30State Street Corporation0.256905466800
2022-06-30OAK HARBOR WEALTH PARTNERS, LLC0.24610.04865236600
2022-06-30Creative Planning Inc0.16930.00013602500
2022-06-30Two Sigma Advisers, LLC0.14940.000231800-48100-60.2003
2022-06-30Sabby Management LLC0.13550.04562883800
2022-06-30Northern Trust Corp0.121402582600
2022-06-30Charles Schwab Investment Management Inc0.0807017180171800
2022-06-30First Horizon Advisors Inc.0.07080.00121506900
2022-06-30OCCUDO QUANTITATIVE STRATEGIES LP0.0520.002111068-1554-12.3118
2022-09-30GREAT VALLEY ADVISOR GROUP, INC.0.05040.001110726107260
2022-06-30Prospera Financial Services Inc0.02120.0006451300
2022-06-30Tower Research Capital LLC0.00570.00011209-1817-60.0463
2022-06-30UBS Group AG0.00480102500
2022-09-30Hanson Mcclain Inc0.00470100010000
Total 14.0380.17622987503+1169632+39.2%

3.2. Funds holding Novan Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-10-31Vanguard Total Stock Mkt Idx Inv2.56260.000154536100
2022-09-30Vanguard Instl Ttl Stck Mkt Idx Tr2.56260.000154536100
2022-10-31Vanguard Extended Market Index Investor0.9860.000320983500
2022-09-30Fidelity® Extended Market Index0.38660.00068227400
2022-10-31iShares Micro-Cap ETF0.18270.00533889100
2022-09-30LUX IM Global Medtech HX0.15820.02593366600
2022-06-30BlackRock Extended Mkt Composite0.14330.000630488304880
2022-09-30BlackRock Extended Equity Market K0.12650.000526919-248-0.9129
2022-09-30Fidelity® Series Total Market Index0.10230.00012178100
2022-09-30Fidelity® Total Market Index0.09610.00012046000
2022-09-30Schwab Total Stock Market Index0.08070.00021718000
2022-10-31iShares Core S&P Total US Stock Mkt ETF0.07260.00011544600
2022-10-31Vanguard Balanced Index Inv0.070401499200
2022-09-30Northern Trust Extended Eq Market Idx0.06260.00061331500
2022-09-30NT Ext Equity Mkt Idx Fd - L0.06260.00061331500
2022-09-30NT Ext Equity Mkt Idx Fd - NL0.05390.00041147100
2022-09-30Fidelity® NASDAQ Composite Index®0.04780.00021016200
2022-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.04350.000592501231.3476
2022-09-30Spartan Total Market Index Pool E0.03540.0001752800
2022-09-30Vanguard U.S. Eq Idx £ Acc0.02820.0001600600
Total 7.86460.03641673701+30363+1.8%

3.3. Insider Transactions

Insiders are holding 5.17% of the shares of Novan Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-04-07James L BiermanBUY10003.454000
2022-03-28James L BiermanBUY10003.45
2022-03-25James L BiermanBUY20003.54
2022-03-18John M GayBUY10003.5
2022-03-18John W PalmourBUY100003.63
2022-03-16John W PalmourBUY50003.34
2021-03-26Paula B StaffordBUY700001.43150693
2019-07-02Life Sciences Holdings L MalinSELL250002.71
2019-06-28Life Sciences Holdings L MalinSELL178002.69
2019-05-28G. Kelly MartinBUY35002.1560000
2019-05-24John W PalmourBUY200002.2293568
2019-05-22Robert Alexander IngramBUY500002.21169777
2019-05-20Paula B StaffordBUY806931.92693
2019-05-17G. Kelly MartinBUY600001.4360000
2019-05-17John M GayBUY149001.515000
2019-05-17Paula B StaffordBUY6931.49693
2018-09-28Robert Alexander IngramBUY500002.84119777
2018-09-26G. Kelly MartinBUY100002.7340000
2018-08-22John W PalmourBUY200002.66273568
2018-08-21G. Kelly MartinBUY300002.7130000

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Novan Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.299-0.236+179%0.380-21%0.001+24967%0.021+1355%
Book Value Growth--0.520-0.565+209%-0.507+197%15.952-97%11.786-96%
Book Value Per Share--0.5760.736-22%0.512+12%0.097+491%0.276+109%
Book Value Per Share Growth--0.520-0.565+209%-0.507+197%15.952-97%11.786-96%
Current Ratio--1.4023.091-55%5.335-74%2.785-50%3.212-56%
Debt To Asset Ratio--0.8930.805+11%0.838+7%1.023-13%0.914-2%
Debt To Equity Ratio--8.3397.744+8%18.930-56%6.316+32%4.738+76%
Dividend Per Share----0%-0%-0%0.009-100%
Eps---0.417-0.434+4%-0.353-15%-0.366-12%-0.533+28%
Eps Growth--0.507-0.040+108%0.114+345%0.300+69%0.402+26%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---1.442-7.437+416%-7.895+448%-7.572+425%-10.082+599%
Operating Margin---1.343-7.394+451%-7.895+488%-7.500+458%-10.030+647%
Operating Ratio--2.4198.357-71%8.900-73%11.193-78%16.899-86%
Pb Ratio2.172-86%4.0487.441-46%13.217-69%-11.619+387%-6.790+268%
Pe Ratio-2.996+46%-5.585-12.337+121%-10.770+93%-6.513+17%-6.602+18%
Peg Ratio---11.014107.948-110%-9.105-17%14.059-178%-31.527+186%
Price Per Share1.250-86%2.3304.645-50%3.229-28%3.058-24%4.242-45%
Price To Total Gains Ratio4.178-86%7.788-9.611+223%-2.826+136%-4.250+155%-5.775+174%
Profit Growth--50.710-4.028+108%11.407+345%18.281+177%12.898+293%
Quick Ratio--1.2542.930-57%5.016-75%2.584-51%3.020-58%
Return On Assets---0.078-0.101+30%-0.147+89%-0.154+99%-0.190+145%
Return On Equity---0.725-0.924+28%-3.519+385%-1.001+38%-0.855+18%
Revenue Growth--0.6870.302+127%-0.159+123%-0.058+108%0.031+2095%
Total Gains Per Share--0.299-0.236+179%0.380-21%0.001+24967%0.029+922%
Total Gains Per Share Growth--2.953-0.940+132%-0.287+110%-0.079+103%-0.317+111%
Usd Book Value--12249000.00015658750.000-22%10901500.000+12%2074250.000+491%5872250.000+109%
Usd Book Value Change Per Share--0.299-0.236+179%0.380-21%0.001+24967%0.021+1355%
Usd Book Value Per Share--0.5760.736-22%0.512+12%0.097+491%0.276+109%
Usd Dividend Per Share----0%-0%-0%0.009-100%
Usd Eps---0.417-0.434+4%-0.353-15%-0.366-12%-0.533+28%
Usd Price Per Share1.250-86%2.3304.645-50%3.229-28%3.058-24%4.242-45%
Usd Profit---8878000.000-9243750.000+4%-7503750.000-15%-7009500.000-21%-8522321.429-4%
Usd Revenue--6158000.0002369500.000+160%988000.000+523%1411100.000+336%1035392.857+495%
Usd Total Gains Per Share--0.299-0.236+179%0.380-21%0.001+24967%0.029+922%
 EOD+2 -3MRQTTM+23 -9YOY+20 -125Y+21 -1110Y+22 -12

4.2. Fundamental Score

Let's check the fundamental score of Novan Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.996
Price to Book Ratio (EOD)Between0-12.172
Net Profit Margin (MRQ)Greater than0-1.442
Operating Margin (MRQ)Greater than0-1.343
Quick Ratio (MRQ)Greater than11.254
Current Ratio (MRQ)Greater than11.402
Debt to Asset Ratio (MRQ)Less than10.893
Debt to Equity Ratio (MRQ)Less than18.339
Return on Equity (MRQ)Greater than0.15-0.725
Return on Assets (MRQ)Greater than0.05-0.078
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Novan Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.160
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-06-302021-09-302021-12-312022-03-312022-06-30
Net Tangible Assets  32,251-6,14126,110-7,86618,244-12,3625,882-29,072-23,190



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets114,392
Total Liabilities102,143
Total Stockholder Equity12,249
 As reported
Total Liabilities 102,143
Total Stockholder Equity+ 12,249
Total Assets = 114,392

Assets

Total Assets114,392
Total Current Assets62,055
Long-term Assets62,055
Total Current Assets
Cash And Cash Equivalents 37,302
Net Receivables 18,217
Inventory 1,559
Other Current Assets 4,977
Total Current Assets  (as reported)62,055
Total Current Assets  (calculated)62,055
+/-0
Long-term Assets
Property Plant Equipment 16,039
Goodwill 3,033
Intangible Assets 32,406
Other Assets 859
Long-term Assets  (as reported)52,337
Long-term Assets  (calculated)52,337
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities44,257
Long-term Liabilities57,886
Total Stockholder Equity12,249
Total Current Liabilities
Short-term Debt 230
Accounts payable 6,756
Other Current Liabilities 34,685
Total Current Liabilities  (as reported)44,257
Total Current Liabilities  (calculated)41,671
+/- 2,586
Long-term Liabilities
Long term Debt 16,500
Capital Lease Obligations Min Short Term Debt3,703
Other Liabilities 12,683
Long-term Liabilities Other 28,311
Long-term Liabilities  (as reported)57,886
Long-term Liabilities  (calculated)61,197
+/- 3,311
Total Stockholder Equity
Common Stock2
Retained Earnings -301,227
Other Stockholders Equity 313,474
Total Stockholder Equity (as reported)12,249
Total Stockholder Equity (calculated)12,249
+/-0
Other
Capital Stock2
Cash and Short Term Investments 37,302
Common Stock Shares Outstanding 20,216
Current Deferred Revenue2,586
Liabilities and Stockholders Equity 114,392
Net Debt -16,869
Net Invested Capital 28,749
Net Tangible Assets -23,190
Net Working Capital 17,798
Short Long Term Debt Total 20,433



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-31
> Total Assets 
9,930
29,840
49,816
44,000
32,734
70,433
52,473
48,572
37,461
29,098
21,134
46,302
38,711
29,695
26,362
21,793
47,509
36,717
29,097
36,510
46,857
46,570
46,829
46,983
79,716
73,887
68,960
112,049
114,392
114,392112,04968,96073,88779,71646,98346,82946,57046,85736,51029,09736,71747,50921,79326,36229,69538,71146,30221,13429,09837,46148,57252,47370,43332,73444,00049,81629,8409,930
   > Total Current Assets 
7,990
27,390
46,933
37,380
22,521
56,121
35,569
31,117
19,696
11,540
3,704
29,038
21,609
12,806
9,350
7,188
32,010
22,447
15,724
23,452
37,728
44,755
44,007
41,178
68,778
61,514
54,130
58,682
62,055
62,05558,68254,13061,51468,77841,17844,00744,75537,72823,45215,72422,44732,0107,1889,35012,80621,60929,0383,70411,54019,69631,11735,56956,12122,52137,38046,93327,3907,990
       Cash And Cash Equivalents 
7,420
26,410
45,688
34,710
19,602
55,664
34,611
30,088
19,067
10,960
2,524
28,100
20,984
12,173
8,194
6,077
22,438
15,549
13,711
21,785
35,458
43,072
35,879
32,661
65,802
59,960
47,085
35,492
37,302
37,30235,49247,08559,96065,80232,66135,87943,07235,45821,78513,71115,54922,4386,0778,19412,17320,98428,1002,52410,96019,06730,08834,61155,66419,60234,71045,68826,4107,420
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
216
419
189
221
157
4,863
4,563
63
121
4,473
16,013
18,217
18,21716,0134,473121634,5634,86315722118941921600000000000000000
       Other Current Assets 
570
980
1,245
2,670
2,919
457
958
1,029
629
580
1,180
938
625
633
1,156
1,111
9,572
6,682
1,594
1,478
2,049
1,526
3,265
3,954
2,913
1,433
2,572
5,699
4,977
4,9775,6992,5721,4332,9133,9543,2651,5262,0491,4781,5946,6829,5721,1111,1566336259381,1805806291,0299584572,9192,6701,245980570
   > Long-term Assets 
1,940
2,450
2,883
6,620
10,213
14,312
16,904
17,455
17,765
17,558
17,430
17,264
17,102
16,889
17,012
14,605
15,499
14,270
13,373
13,058
9,129
1,815
2,822
5,805
10,938
12,373
14,830
53,367
52,337
52,33753,36714,83012,37310,9385,8052,8221,8159,12913,05813,37314,27015,49914,60517,01216,88917,10217,26417,43017,55817,76517,45516,90414,31210,2136,6202,8832,4501,940
       Property Plant Equipment 
1,920
2,450
2,344
6,010
9,598
13,698
16,290
16,546
16,938
16,738
16,624
16,474
16,327
16,129
15,868
13,490
12,891
12,406
12,339
12,057
8,156
1,410
2,406
4,937
10,089
11,532
13,894
15,533
16,039
16,03915,53313,89411,53210,0894,9372,4061,4108,15612,05712,33912,40612,89113,49015,86816,12916,32716,47416,62416,73816,93816,54616,29013,6989,5986,0102,3442,4501,920
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,002
3,033
3,0334,002000000000000000000000000000
       Intangible Assets 
0
0
0
80
75
75
75
75
75
75
75
75
0
0
75
75
75
75
75
75
75
75
75
75
75
75
75
32,954
32,406
32,40632,9547575757575757575757575757500757575757575757580000
       Long-term Assets Other 
20
0
539
530
540
539
539
834
752
745
731
790
775
760
1,144
1,115
2,608
1,864
959
1,001
973
405
341
793
774
766
861
878
859
8598788617667747933414059731,0019591,8642,6081,1151,144760775790731745752834539539540530539020
> Total Liabilities 
1,780
3,460
109,897
10,280
16,768
27,019
21,407
27,840
25,720
23,897
23,356
34,923
34,359
31,991
21,164
24,156
67,725
64,322
52,884
48,870
46,894
39,117
43,852
46,133
47,390
47,702
50,641
106,167
102,143
102,143106,16750,64147,70247,39046,13343,85239,11746,89448,87052,88464,32267,72524,15621,16431,99134,35934,92323,35623,89725,72027,84021,40727,01916,76810,280109,8973,4601,780
   > Total Current Liabilities 
1,770
3,450
5,095
7,610
11,628
19,233
13,377
11,502
9,986
8,424
8,418
7,364
8,160
7,804
9,061
10,723
17,924
17,638
12,899
11,767
9,491
8,049
8,700
8,585
11,605
12,666
11,150
46,975
44,257
44,25746,97511,15012,66611,6058,5858,7008,0499,49111,76712,89917,63817,92410,7239,0617,8048,1607,3648,4188,4249,98611,50213,37719,23311,6287,6105,0953,4501,770
       Short-term Debt 
0
0
10
0
0
10
10
10
10
11
11
11
11
11
0
1,139
0
0
0
0
0
119
478
836
0
0
3,613
228
230
2302283,61300836478119000001,1390111111111110101010001000
       Short Long Term Debt 
0
0
10
0
0
0
8,040
10
8,035
8,033
8,030
8,028
8,025
0
0
1,139
0
0
0
0
0
119
478
836
0
0
0
0
0
00000836478119000001,139008,0258,0288,0308,0338,035108,0400001000
       Accounts payable 
950
1,000
1,626
810
1,476
5,024
3,130
2,002
1,351
937
479
828
1,056
386
1,250
1,510
957
2,495
1,602
997
1,269
172
1,192
1,001
1,800
2,919
2,170
4,753
6,756
6,7564,7532,1702,9191,8001,0011,1921721,2699971,6022,4959571,5101,2503861,0568284799371,3512,0023,1305,0241,4768101,6261,000950
       Other Current Liabilities 
820
2,450
3,469
6,800
10,152
14,209
10,247
7,097
6,229
5,346
5,775
3,898
4,509
4,823
3,410
4,812
12,566
10,742
6,869
6,369
3,821
3,357
4,040
3,758
6,815
7,161
6,394
36,171
34,685
34,68536,1716,3947,1616,8153,7584,0403,3573,8216,3696,86910,74212,5664,8123,4104,8234,5093,8985,7755,3466,2297,09710,24714,20910,1526,8003,4692,450820
   > Long-term Liabilities 
10
10
104,802
2,670
5,140
7,786
8,030
16,338
15,734
15,473
14,938
27,559
26,199
24,187
12,103
13,433
49,801
46,684
39,985
37,103
37,403
31,068
35,152
37,548
35,785
35,036
39,491
59,192
57,886
57,88659,19239,49135,03635,78537,54835,15231,06837,40337,10339,98546,68449,80113,43312,10324,18726,19927,55914,93815,47315,73416,3388,0307,7865,1402,670104,8021010
       Long term Debt Total 
0
0
0
0
0
34
32
30
27
24
21
19
16
13
8,008
0
0
0
0
0
956
837
478
120
0
0
0
0
0
00000120478837956000008,00813161921242730323400000
       Other Liabilities 
0
0
0
0
0
0
7,998
8,310
7,709
7,451
6,919
19,542
18,185
16,176
4,095
7,889
19,406
16,435
9,885
7,156
6,665
5,231
9,674
37,548
7,690
7,063
10,878
59,192
12,683
12,68359,19210,8787,0637,69037,5489,6745,2316,6657,1569,88516,43519,4067,8894,09516,17618,18519,5426,9197,4517,7098,3107,998000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
8,310
7,709
7,451
6,919
19,542
13,537
12,073
0
1,628
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001,628012,07313,53719,5426,9197,4517,7098,3100000000
> Total Stockholder Equity
8,150
26,390
-60,081
33,720
15,966
43,414
31,066
20,732
11,741
5,201
-2,222
11,379
4,352
-2,296
5,198
-2,363
-20,216
-27,605
-23,787
-12,360
-37
7,453
2,977
850
32,326
26,185
18,319
5,882
12,249
12,2495,88218,31926,18532,3268502,9777,453-37-12,360-23,787-27,605-20,216-2,3635,198-2,2964,35211,379-2,2225,20111,74120,73231,06643,41415,96633,720-60,08126,3908,150
   Common Stock
0
0
0
0
1
2
2
2
2
2
2
3
3
3
3
3
3
3
3
7
12
14
14
15
2
2
2
2
2
222221514141273333333322222210000
   Retained Earnings -301,227-292,349-278,969-270,736-264,252-258,229-249,277-242,642-234,237-226,151-203,682-206,500-198,164-180,066-172,327-179,480-172,449-164,871-160,160-151,971-144,527-134,640-123,033-109,972-92,498-74,590-63,334-46,840-29,950
   Accumulated Other Comprehensive Income 0000000-1,201-9,032-6,118-5,679-5,175-4,664-4,177-4,588-4,171-3,748-3,436-3,035-2,672-3,041-2,738-2,438-2,256-2,132-1,930-1,751-1,600-3,052,780
   Capital Surplus 
0
0
0
0
0
153,539
154,252
155,525
156,421
157,325
158,091
176,402
176,953
177,336
177,677
177,855
178,100
179,047
180,047
213,939
234,343
250,236
252,395
259,219
296,731
297,074
0
0
0
000297,074296,731259,219252,395250,236234,343213,939180,047179,047178,100177,855177,677177,336176,953176,402158,091157,325156,421155,525154,252153,53900000
   Treasury Stock000-155-155-155-155-155-155-155-155-155-155-155-155-155-155-155-155-155-155-155-155-155-1550000
   Other Stockholders Equity 
3,090,880
74,830
5,004
110,240
110,595
155,640
156,535
158,108
159,307
159,842
160,971
179,683
180,546
181,352
182,110
181,877
182,609
184,067
185,571
219,902
243,220
251,282
252,240
259,064
296,576
296,919
297,286
298,229
313,474
313,474298,229297,286296,919296,576259,064252,240251,282243,220219,902185,571184,067182,609181,877182,110181,352180,546179,683160,971159,842159,307158,108156,535155,640110,595110,2405,00474,8303,090,880



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue2,958
Cost of Revenue--
Gross Profit-2,958
 
Operating Income (+$)
Gross Profit-
Operating Expense-32,759
Operating Income-29,915-32,759
 
Operating Expense (+$)
Research Development20,416
Selling General Administrative12,343
Selling And Marketing Expenses-
Operating Expense32,75932,759
 
Net Interest Income (+$)
Interest Income13
Interest Expense-13
Net Interest Income130
 
Pretax Income (+$)
Operating Income-29,915
Net Interest Income13
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-29,692-30,138
EBIT - interestExpense = -29,692
-29,692
-29,679
Interest Expense13
Earnings Before Interest and Taxes (ebit)-29,679-29,679
Earnings Before Interest and Taxes (ebitda)-29,335
 
After tax Income (+$)
Income Before Tax-29,692
Tax Provision--
Net Income From Continuing Ops-29,692-29,692
Net Income-29,692
Net Income Applicable To Common Shares-29,692
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses32,759
Total Other Income/Expenses Net223-13
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
PRU.TO
2 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PRU.TO.

PRU.TO Daily Candlestick Chart
XSQ.TO
8 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of XSQ.TO.

XSQ.TO Daily Candlestick Chart
NA.TO
10 minutes ago

I found you a Golden Cross on the daily chart of NA.TO.

NA.TO Daily Candlestick Chart
MNT.TO
11 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MNT.TO.

MNT.TO Daily Candlestick Chart
MOGO.TO
11 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MOGO.TO.

MOGO.TO Daily Candlestick Chart
L.TO
16 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of L.TO.

L.TO Daily Candlestick Chart
HZD.TO
19 minutes ago

I found you a Death Cross on the daily chart of HZD.TO.

HZD.TO Daily Candlestick Chart
TLGN.PINK
23 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of TLGN.PINK.

TLGN.PINK Daily Candlestick Chart
GXE.TO
24 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GXE.TO.

GXE.TO Daily Candlestick Chart
NHK.TO
27 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of NHK.TO.

NHK.TO Daily Candlestick Chart
ZMU.TO
28 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ZMU.TO.

ZMU.TO Daily Candlestick Chart
PNPN.V
31 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PNPN.V.

PNPN.V Daily Candlestick Chart
TRL.TO
31 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of TRL.TO.

TRL.TO Daily Candlestick Chart
VBNK.TO
33 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VBNK.TO.

VBNK.TO Daily Candlestick Chart
VCB.TO
35 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VCB.TO.

VCB.TO Daily Candlestick Chart
ZDH.TO
37 minutes ago

I found you a Golden Cross on the daily chart of ZDH.TO.

ZDH.TO Daily Candlestick Chart
MUS.TO
37 minutes ago

I found you a Golden Cross on the daily chart of MUS.TO.

MUS.TO Daily Candlestick Chart
VRIF.TO
39 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VRIF.TO.

VRIF.TO Daily Candlestick Chart
ZLC.TO
40 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ZLC.TO.

ZLC.TO Daily Candlestick Chart
XLY.TO
42 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of XLY.TO.

XLY.TO Daily Candlestick Chart
XGB.TO
43 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of XGB.TO.

XGB.TO Daily Candlestick Chart
XCB.TO
43 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of XCB.TO.

XCB.TO Daily Candlestick Chart
WILD.TO
44 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of WILD.TO.

WILD.TO Daily Candlestick Chart
VLNS.TO
45 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of VLNS.TO.

VLNS.TO Daily Candlestick Chart
TXG.TO
46 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TXG.TO.

TXG.TO Daily Candlestick Chart